0

524572

PHARMAID

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

PHARMAIDS PHARMACEUTICALS LTD. Share Price Today

Investment Returns

Over 1 Month 36.55% Over 3 Months 18.78% Over 6 Months -22.28% Over 1 Year -33.81%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

PHARMAIDS PHARMACEUTICALS LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 133.60
  • P/E Ratio (TTM) -12.80
  • Beta 0.42
  • Book Value / share 15.13
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -1.31
info icon alternate text

PHARMAIDS PHARMACEUTICALS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 2.69
Operating Expense 4.42
Net Profit -1.31
Net Profit Margin (%) -48.69
Earnings Per Share (EPS) -0.37
EBITDA -1.03
Effective Tax Rate (%) 22.48
Particulars DEC 2025 (Values in Cr)
Revenue 0.83
Operating Expense 5.13
Net Profit -3.11
Net Profit Margin (%) -374.69
Earnings Per Share (EPS) -0.88
EBITDA -3.62
Effective Tax Rate (%) 26.65
Particulars SEP 2025 (Values in Cr)
Revenue 5.97
Operating Expense 11.62
Net Profit -1.65
Net Profit Margin (%) -27.63
Earnings Per Share (EPS) -0.47
EBITDA -1.25
Effective Tax Rate (%) 29.18
Particulars JUN 2025 (Values in Cr)
Revenue 1.12
Operating Expense 7.15
Net Profit -4.36
Net Profit Margin (%) -389.28
Earnings Per Share (EPS) -1.24
EBITDA -4.53
Effective Tax Rate (%) 23.37
Particulars MAR 2025 (Values in Cr)
Revenue 0.13
Operating Expense 4.92
Net Profit -3.06
Net Profit Margin (%) -2353.84
Earnings Per Share (EPS) -0.86
EBITDA -1.68
Effective Tax Rate (%) 19.04
Particulars MAR 2026 (Values in Cr)
Revenue 10.60
Operating Expense 28.33
Net Profit -10.44
Net Profit Margin (%) -98.49
Earnings Per Share (EPS) -2.95
EBITDA -10.43
Effective Tax Rate (%) 25.23
Particulars MAR 2025 (Values in Cr)
Revenue 2.34
Operating Expense 11.95
Net Profit -7.28
Net Profit Margin (%) -311.11
Earnings Per Share (EPS) -2.06
EBITDA -6.23
Effective Tax Rate (%) 15.25
Particulars MAR 2024 (Values in Cr)
Revenue 0.03
Operating Expense 6.91
Net Profit -4.95
Net Profit Margin (%) -16500.00
Earnings Per Share (EPS) -2.18
EBITDA -5.58
Effective Tax Rate (%) 18.71
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 9.91
Net Profit -7.56
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -5.86
EBITDA -9.89
Effective Tax Rate (%) 23.71
Particulars MAR 2022 (Values in Cr)
Revenue 3.94
Operating Expense 3.81
Net Profit 0.15
Net Profit Margin (%) 3.80
Earnings Per Share (EPS) 0.14
EBITDA 0.15
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 16.82
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.36
EBITDA Margin -65.50
Particulars MAR 2024 (Values in Cr)
Book Value / Share 20.43
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.09
EBITDA Margin -81.54
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.31
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.44
ROE % 1.36
ROCE % 1.36
Total Debt to Total Equity 0.00
EBITDA Margin 3.81
Particulars MAR 2025 (Values in Cr)
Book Value / Share 18.09
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.39
EBITDA Margin -266.67
Particulars MAR 2024 (Values in Cr)
Book Value / Share 20.15
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.14
EBITDA Margin -18600.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.46
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.44
ROE % 1.36
ROCE % 1.36
Total Debt to Total Equity 0.00
EBITDA Margin 3.81
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.30
ROE % 0.82
ROCE % 0.82
Total Debt to Total Equity 0.00
EBITDA Margin 1.52
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.14
Total Assets 119.85
Total Liabilities 119.85
Total Equity 55.04
Share Outstanding 3
Price to Book Ratio 3.80
Return on Assets (%) -8.99
Return on Capital (%) -11.94
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.80
Total Assets 91.34
Total Liabilities 91.34
Total Equity 70.49
Share Outstanding 3
Price to Book Ratio 2.58
Return on Assets (%) -8.72
Return on Capital (%) -10.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.75
Total Assets 24.58
Total Liabilities 24.58
Total Equity 22.46
Share Outstanding 2
Price to Book Ratio 2.09
Return on Assets (%) -30.72
Return on Capital (%) -33.64
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 11.11
Total Liabilities 11.11
Total Equity 8.67
Share Outstanding 1
Price to Book Ratio 1.48
Return on Assets (%) 1.30
Return on Capital (%) 1.67
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.46
Total Assets 118.68
Total Liabilities 118.68
Total Equity 63.78
Share Outstanding 3
Price to Book Ratio 3.80
Return on Assets (%) -6.13
Return on Capital (%) -7.05
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.45
Total Assets 85.00
Total Liabilities 85.00
Total Equity 71.06
Share Outstanding 3
Price to Book Ratio 2.58
Return on Assets (%) -5.82
Return on Capital (%) -5.92
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.75
Total Assets 24.54
Total Liabilities 24.54
Total Equity 22.42
Share Outstanding 2
Price to Book Ratio 2.09
Return on Assets (%) -30.77
Return on Capital (%) -33.69
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 11.11
Total Liabilities 11.11
Total Equity 8.67
Share Outstanding 1
Price to Book Ratio 1.48
Return on Assets (%) 1.30
Return on Capital (%) 1.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 9.11
Total Liabilities 9.11
Total Equity 8.52
Share Outstanding 1
Price to Book Ratio 1.35
Return on Assets (%) 1.02
Return on Capital (%) 1.09
Particulars MAR 2025 (Values in Cr)
Net Income -17.27
Cash from Operations -13.92
Cash from Investing -12.02
Cash from Financing 23.35
Net change in Cash -2.65
Free Cash Flow -1.44
Particulars MAR 2024 (Values in Cr)
Net Income -15.62
Cash from Operations -10.61
Cash from Investing -74.99
Cash from Financing 77.65
Net change in Cash -7.95
Free Cash Flow 12.24
Particulars MAR 2023 (Values in Cr)
Net Income -9.90
Cash from Operations -4.01
Cash from Investing -4.94
Cash from Financing 21.30
Net change in Cash 12.34
Free Cash Flow -2.34
Particulars MAR 2022 (Values in Cr)
Net Income 0.14
Cash from Operations -0.25
Cash from Investing 0.46
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow -0.25
Particulars MAR 2025 (Values in Cr)
Net Income -8.58
Cash from Operations -7.72
Cash from Investing -18.90
Cash from Financing 24.63
Net change in Cash -1.99
Free Cash Flow 1.31
Particulars MAR 2024 (Values in Cr)
Net Income -6.08
Cash from Operations -3.44
Cash from Investing -72.50
Cash from Financing 65.65
Net change in Cash -10.29
Free Cash Flow 12.92
Particulars MAR 2023 (Values in Cr)
Net Income -9.90
Cash from Operations -4.01
Cash from Investing -4.94
Cash from Financing 21.31
Net change in Cash 12.35
Free Cash Flow -2.34
Particulars MAR 2022 (Values in Cr)
Net Income 0.14
Cash from Operations -0.25
Cash from Investing 0.46
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow -0.25
Particulars MAR 2021 (Values in Cr)
Net Income 0.08
Cash from Operations 0.40
Cash from Investing -0.22
Cash from Financing 0.00
Net change in Cash 0.17
Free Cash Flow 0.40
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.51 13.02 1.52 241.47 23.12 38.85
BLISS GVS PHARMA LTD 492.50 39.98 4.37 5223.27 118.35 495.00
CIPLA LTD. 1440.30 30.57 3.37 116353.96 1165.55 1672.20
FERMENTA BIOTECH LTD. 365.50 16.12 2.64 1075.70 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.51 22.03 4.05 241.47 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 538.05 24.12 4.20 1555.54 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8382.65 109.48 24.01 20956.63 7630.00 9850.00
BLISS GVS PHARMA LTD 492.50 53.13 4.52 5223.27 118.35 495.00

PHARMAIDS PHARMACEUTICALS LTD. shareholding pattern

Holding
67.01%
32.98%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

PHARMAIDS PHARMACEUTICALS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
37.88 10.40 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 35.00
  • 26 Days 31.10
  • 10 Days 33.20
  • 50 Days 31.10
  • 12 Days 32.70
  • 100 Days 33.80
  • 20 Days 31.50
  • 200 Days 39.70
34.69 PIVOT
First Support 32.87 First Resistance 36.12 Second Support 31.44 Second Resistance 37.94 Third Support 29.62 Third Resistance 39.37
RSI 71.33 ADX 34.17 MACD 1.62 Williams % R -14.35 Commodity Channel Index (CCI) 170.84
Date 2026-06-25 Week 17715.00 Same Day 22535.00 Month 17568.00
1 Year 0.42 3 Year 0.22
Over 1 Month
36.55% down
Over 1 Year
-33.81% down
Over 3 Months
18.78% down
Over 3 Years
-0.34% down
Over 6 Months
-22.28% down
Over 5 Years
16.30% down

PHARMAIDS PHARMACEUTICALS LTD. Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Pharmaids Pharmaceuticals Ltd?

Answer Field

Pharmaids Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 37.88 as on Jun 25 2026 03:27 PM.

What is the Market Cap of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

The market cap of Pharmaids Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 133.60 as on Jun 25 2026 03:27 PM.

What is the 52 Week High and Low of Pharmaids Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Pharmaids Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 70.00 and ₹ 25.60.

What is 1 year return for Pharmaids Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -33.81%.

What is the P/E Ratio of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

As on Jun 25 2026 03:27 PM the price-to-earnings (PE) ratio for Pharmaids Pharmaceuticals Ltd share is -12.80.

What is the PB ratio of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

As on Jun 25 2026 03:27 PM, the price-to-book (PB) ratio for Pharmaids Pharmaceuticals Ltd share is 15.13.

How to Buy Pharmaids Pharmaceuticals Ltd Share?

Answer Field

You can trade in Pharmaids Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Pharmaids Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Pharmaids Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Pharmaids Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|